GlassScriptPhysician profile
Vicken S Chalian
NPI 1871529594
$9,338.89
in general payments reported to CMS, 2019-2025
53 companies · $1,399 in 2025
The $1,399 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $648 · 2020: $652 · 2021: $1,825 · 2022: $1,234 · 2023: $1,792 · 2024: $1,790 · 2025: $1,399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,769 · Education: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,768.86 |
| Education | $212.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $869.73 | 2019-2024 | Xtandi, Myrbetriq |
| Abbvie INC. | $736.06 | 2019-2025 | Lupron Depot |
| Merck Sharp & Dohme LLC | $622.91 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $611.27 | 2019-2025 | Erleada |
| Boston Scientific Corporation | $556.21 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700, Axonics |
| Sumitomo Pharma America, INC. | $510.65 | 2023-2025 | Gemtesa, Orgovyx |
| Myriad Genetic Laboratories, INC. | $487.33 | 2020-2025 | Prolaris, Myrisk |
| Dendreon Pharmaceuticals LLC | $474.86 | 2021-2025 | Provenge |
| Convatec INC. | $426.14 | 2019-2024 | |
| Olympus America INC. | $377.81 | 2019-2025 | Itind System, Soltive |
| Endo Pharmaceuticals INC. | $309.61 | 2019-2024 | Edex, Aveed, Xiaflex |
| Axonics, INC. | $307.88 | 2020-2024 | Axonics |
| Ferring Pharmaceuticals INC. | $303.03 | 2019-2025 | Adstiladrin |
| Pfizer INC. | $286.26 | 2019-2025 | |
| Procept Biorobotics Corporation | $253.40 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicken Chalian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.